Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    14633962 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment
Conditions: Hepatitis;   Tuberculosis;   hepatitisB
Intervention: Drug: entecavir (BARACLUDE®)

Study has passed its completion date and status has not been verified in more than two years.